| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―Aug―24 |
Methodological Considerations in the PACT Trial of Multimodal Repurposed Therapy for COVID-19 |
Metin Öner, İbrahim Altundağ |
| 2 |
[GO] |
2026―Jun―05 |
“Comment on: Safety and Tolerability of Multimodal Therapy (Ivermectin, Doxycycline, Vitamin C, Vitamin D, and Zinc) With or Without Famotidine in Australian Patients With COVID-19 Infection: A Pilot Cohort Trial,” for Potential Publication in the American Journal of Therapeutics |
Nawazish Ali, Muneeba Attique, Musawar Khan, Aqib Ali, Atif Hussain |
| 3 |
[GO] |
2026―Feb―16 |
Safety and Tolerability of Multimodal Therapy (Ivermectin, Doxycycline, Vitamin C, Vitamin D, and Zinc) With or Without Famotidine in Australian Patients With COVID-19 Infection: A Pilot Cohort Trial |
Lucas A. McLindon, Karin Ried, Bruce Wauchope, Lucia Murnane, Elizabeth Harradine, Josie Seman |
| 4 |
[GO] |
2025―Nov―07 |
Medication Adjustments in a Schizophrenia Patient With Obesity and Asthma During COVID-19 Infection |
Tsukasa Murata, Shiro Furusho, Takahiko Nagamine |
| 5 |
[GO] |
2025―Jul―02 |
Clozapine and Electroconvulsive Therapy Achieved Sustained Remission of Malignant Catatonia Following a COVID-19 Infection |
Szu-Hao An, Wan-Ting Chen, Yi-Guang Wang, Hsun Ou, Nian-Sheng Tzeng |
| 6 |
[GO] |
2025―Jul―02 |
Changes in Raphe Nucleus Blood Flow May Serve as a Therapeutic Indicator in Transcranial Magnetic Stimulation Treatment for Long COVID Neuropsychiatric Symptoms: A Case Report |
Chu-Ya Yang, Hao-Wen Cheng, Chih-Chung Huang, Hsin-An Chang, Ta-Chuan Yeh |
| 7 |
[GO] |
2025―Jan―06 |
Enhancing the Evidence Base for the Efficacy of Nirmatrelvir-Ritonavir in Preventing COVID-19 Hospitalization and Mortality: A Call for Comprehensive Research Strategies |
|
| 8 |
[GO] |
2024―Dec―13 |
Late-Onset Inflammatory Bowel Disease and Flares In Adenoviral and Inactivated Coronavirus Vaccine Recipients |
Upinder Kaur, Dondapati Venkata Vamshi Krishna, Jaideep Reddy, Noti Taruni Srija Reddy, Amol Dehade, Sankha Shubhra Chakrabarti, Dawesh Prakash Yadav |
| 9 |
[GO] |
2024―Nov―13 |
An Investigation Into the Clinical Characteristics and Management Strategies for Patients With Lymphoma and Concomitant COVID-19 |
Hu Liu, Gui-Qin Wang, Liao Wang, Fang Gao, Shu-Ling Hou |
| 10 |
[GO] |
2024―May―01 |
Effectiveness of Nirmatrelvir-Ritonavir for the Prevention of COVID-19-Related Hospitalization and Mortality: A Systematic Literature Review |
Ashley S. Cha-Silva, Meghan B. Gavaghan, Tobias Bergroth, Ronika Alexander-Parrish, Jingyan Yang, Florin Draica, et al. (+6) Jaymin Patel, Denise A. Garner, Richard H. Stanford, Genevieve Meier, John M. McLaughlin, Jennifer L. Nguyen |
| 11 |
[GO] |
2024―May―01 |
Commentary on Effectiveness of Nirmatrelvir-Ritonavir for the Prevention of COVID-19-Related Hospitalization and Mortality: A Systematic Literature Review |
Daniel O. Griffin |
| 12 |
[GO] |
2024―Mar―22 |
Premature Closure of Scientific Thinking: Deaths Due to Chloroquine and Hydroxychloroquine Used for COVID-19 Infection |
Peter Manu |
| 13 |
[GO] |
2024―Jan―23 |
Favipiravir for the Treatment of Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis of Randomized Controlled Trials |
Aiman Naveed, Huzaifa Ahmad Cheema, Abia Shahid, Mohammad Umer, Hassan ul Hussain, Mohammad Ebad Ur Rehman, et al. (+6) Harpreet Singh, Jonathan S. Kurman, Syeda Sahra, Faran Ahmad, Sharjeel Ahmad, Sana Iqbal |
| 14 |
[GO] |
2024―Jan―16 |
Clinical Observation of Trimetazidine Combined With Coenzyme Q10 in the Treatment of Myocardial Damage Caused by COVID-19 |
Xiaochun Ye, Shaohui Zhang |
| 15 |
[GO] |
2024―Jan―16 |
Myocarditis in Three Japanese Men After the Second mRNA-Based COVID-19 Vaccine Dose |
Tomiko Sunaga, Michiko Tanaka, Hiromoto Sone, Tatsuya Onuki, Daisuke Wada, Hiroshi Suzuki |
| 16 |
[GO] |
2024―Jan―16 |
Molnupiravir for the Treatment of Coronavirus Disease 2019: A Systematic Review With Meta-Analysis of 12,451 Patients |
Azizullah Beran, Asmaa Mhanna, Mohammed Mhanna, David Farrow, Sabeen Sidiki, Yasmin Khader, et al. (+2) Omar Srour, Ammar Kayyali |
| 17 |
[GO] |
2023―Sep―15 |
Fatal Myocarditis After COVID-19 Vaccination: Fourteen Autopsy-Confirmed Cases: Erratum |
|
| 18 |
[GO] |
2023―Aug―30 |
Efficacy and Safety of Favipiravir for the Treatment of COVID-19 Outpatients: A Systematic Review and Meta-analysis of Randomized Controlled Trials |
Huzaifa Ahmad Cheema, Abraish Ali, Mirha Ali, Abia Shahid, Muhammad Saqib Ghafoor, Mohammad Ebad Ur Rehman, et al. (+3) Ranjit Sah, Syeda Sahra, Sharjeel Ahmad |
| 19 |
[GO] |
2023―May―26 |
Therapeutic Vaccination Is the Most Promising Intervention for Long COVID |
Peter Manu |
| 20 |
[GO] |
2023―May―18 |
Tocilizumab and Corticosteroids Increase Risk of COVID-19-Associated Pulmonary Aspergillosis Development Among Critically Ill Patients |
Mohammed T. Awad, Rajmund Michal Niwinski, Azizullah Beran, Chad Tidwell, Ayman O. Soubani |
| 21 |
[GO] |
2023―May―18 |
Therapeutic Messianism: Belladonna for Heroin Withdrawal, Ivermectin for COVID-19 Infection |
Peter Manu |
| 22 |
[GO] |
2023―May―18 |
Erythema Multiforme Induced by Zonisamide and Triggered by the First Dose of COVID-19 Vaccine (Pfizer-BioNTech) |
Tsukasa Murata, Yoshitaka Nobukuni |
| 23 |
[GO] |
2023―May―18 |
Fatal Myocarditis After COVID-19 Vaccination: Fourteen Autopsy-Confirmed Cases |
Peter Manu |
| 24 |
[GO] |
2023―Apr―25 |
Outcome of COVID-19 mRNA Vaccination in Patients Treated With Clozapine WHO Previously Went Through SARS-COV-2 Infection |
Silvia Moga, Paula Simina Petric, Ana Aliana Miron, Petru Ifteni, Andreea Teodorescu |
| 25 |
[GO] |
2023―Apr―17 |
Against Authority: The Bioethics of Ivermectin Use for COVID-19 Infection |
Vasile Astărăstoae, Liliana M. Rogozea |
| 26 |
[GO] |
2023―Mar―07 |
Rituximab for COVID-19 Vaccine-Associated Pemphigus Vulgaris |
Hai-Zhen Hui, Ying-Jun Wang, Jia-Rong Cheng, Han Mao, Hong-Xing Guo, Qing-Chun Diao, Bing-Jun Shi |
| 27 |
[GO] |
2023―Mar―01 |
Antidepressants Are Associated With a Reduction in the Risk of Death in COVID-19 Disease Patients |
Raquel Cobos-Campos, Arantza Sáez de Lafuente-Moríñigo, José Aurelio Cordero-Guevara, Cristina Bermúdez-Ampudia, Antxon Apiñaniz, Julene Argaluza, Naiara Parraza |
| 28 |
[GO] |
2023―Feb―22 |
Anakinra-An Interleukin-1 Receptor Antagonist for COVID-19 |
Timothy Nguyen, Lorena Dima, Kristine C. Willett |
| 29 |
[GO] |
2023―Feb―10 |
Ivermectin and the Emergence of Long COVID |
Peter Manu |
| 30 |
[GO] |
2022―Nov―09 |
Same-Day Deaths After COVID-19 Vaccinations: Autopsy Findings in 54 Cases |
Peter Manu |
| 31 |
[GO] |
2022―Nov―09 |
Ivermectin for COVID-19: The 2022 Update |
Peter Manu |
| 32 |
[GO] |
2022―Nov―09 |
Aromatherapy and Fermented Fruits for Long COVID: Placebo-Controlled Placebo Trials? |
Peter Manu |
| 33 |
[GO] |
2022―Aug―19 |
Remdesivir Administration in COVID-19 Patients With Renal Impairment: A Systematic Review |
Effat Davoudi-Monfared, Arezoo Ahmadi, Elahe Karimpour-Razkenari, Bita Shahrami, Farhad Najmeddin, Mojtaba Mojtahedzadeh |
| 34 |
[GO] |
2022―Jul―08 |
Re: Expression of Concern for Bryant A, Lawrie TA, Dowswell T, Fordham EJ, Mitchell S, Hill SR, Tham TC. Ivermectin for Prevention and Treatment of COVID-19 Infection. Am J Ther. 2022;29:e232. |
Andrew Bryant, Theresa A. Lawrie, Edmund J. Fordham, Scott Mitchell |
| 35 |
[GO] |
2022―Jul―08 |
Angiotensin II Receptor Blocking Drugs May Increase Severity of Coronavirus Disease 2019 Infection |
Raquel Cobos-Campos, Cristina Bermúdez-Ampudia, Estibaliz Orruño, Antxon Apiñaniz, Sainza García, Jose Cordero, et al. (+3) Julene Argaluza, Arantza Sáez de Lafuente, Naiara Parraza |
| 36 |
[GO] |
2022―Jun―24 |
Neutropenia in Patients With Clozapine-Treated Schizophrenia: An Effect of Clozapine or a Consequence of SARS-CoV-2 Infection? A Systematic Review |
Silvia Moga, Andreea Teodorescu, Ana Dragan, Ana Aliana Miron, Petru Ifteni |
| 37 |
[GO] |
2022―Jun―20 |
Plausibility of Claimed Covid-19 Vaccine Efficacies by Age: A Simulation Study |
Kyle A. Sheldrick, Gideon Meyerowitz-Katz, Greg Tucker-Kellogg |
| 38 |
[GO] |
2022―May―09 |
Methylprednisolone Versus Dexamethasone in COVID-19: A Meta-Analysis of Nonrandomized Studies |
Azizullah Beran, Hazem Ayesh, Mohammed Mhanna, Omar Srour, Rami Musallam, Wasef Sayeh, et al. (+5) Waleed Khokher, Nehaya Altorok, Zaid Noori, Ragheb Assaly, Nezam Altorok |
| 39 |
[GO] |
2022―May―09 |
Methylprednisolone May Be Superior to Dexamethasone in COVID-19: A Meta-Analysis of Randomized Controlled Trials |
Azizullah Beran, Hazem Ayesh, Mohammed Mhanna, Omar Srour, Rami Musallam, Wasef Sayeh, et al. (+5) Waleed Khokher, Nehaya Altorok, Zaid Noori, Ragheb Assaly, Nezam Altorok |
| 40 |
[GO] |
2022―Apr―27 |
Use of Anticoagulants in COVID-19: A Review |
Sam Ngu, John Kolton Smith, Mark Goldin |
| 41 |
[GO] |
2022―Apr―21 |
The Effect of Colchicine on Mortality, Mechanical Ventilation, and Length of Stay in Patients With COVID-19 Infection: An Updated Systematic Review and Meta-analysis of Randomized Clinical Trials |
Francisco José Romeo, Leandro Barbagelata, Juan Guido Chiabrando, Juan Ignacio Damonte, Errol Moras, Jose S. Aguilar-Gallardo, et al. (+3) Marta Lorente-Ros, Lorenzo Martin Lobo, Walter Masson |
| 42 |
[GO] |
2022―Apr―19 |
Preinfection Anticoagulation/Antiplatelet Therapy Does Not Influence the Outcome of COVID-19 Disease in Hospitalized Patients |
Jasmeet Kaur, Yaqub N. Mohammed, Amar Lal, Mayuri Kulkarni, Priyanjali Pulipati, Priyadarshini Dixit, et al. (+7) Yi Lee, Asrar Abdou, Qasim Jehangir, Mohammed Ibrahim, Mohamed N. Mandeel, Mariam Qamar, Jacky Duong |
| 43 |
[GO] |
2022―Apr―05 |
Fluvoxamine in Nonhospitalized Patients With Acute COVID-19 Infection and the Lack of Efficacy in Reducing Rates of Hospitalization, Mechanical Ventilation, and Mortality in Placebo-Controlled Trials: A Systematic Review and Meta-Analysis |
Sapan Bhuta, Waleed Khokher, Nithin Kesireddy, Saffa Iftikhar, Azizullah Beran, Mohammed Mhanna, et al. (+4) Neha J. Patel, Mitra Patel, Cameron Burmeister, Ragheb Assaly |
| 44 |
[GO] |
2022―Apr―05 |
Fluvoxamine for Acute COVID-19 Infection: Weak Hypothesis, Predictable Failure |
Peter Manu |
| 45 |
[GO] |
2022―Apr―05 |
Pneumonitis and Myopericarditis After Booster COVID-19 mRNA Vaccination |
Ravi B. Singh, Muizz Zaman, Alanna M. Glidden, Sanchari Banerjee, Atika Azhar, Hayas H. Koya, Harvir S. Gambhir |
| 46 |
[GO] |
2022―Apr―05 |
Dose-Dependent Ivermectin Effect on COVID-19 Polymerase Chain Reaction Status |
Nirmeen Sabry, Yasser Fouad, Mohamed AbdAllah, Ahmed Cordie, Gamal Esmat |
| 47 |
[GO] |
2022―Apr―05 |
A Scoping Review of Pharmacological Management of Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 2021 |
Erin Carson, Alice N. Hemenway |
| 48 |
[GO] |
2022―Apr―05 |
Aortic Mural Thrombosis Diagnosed After a Second Dose of mRNA-1273 SARS-CoV-2 Vaccine |
Shoheera Punjwani, Prateek Khanna, Chinmay Jani, Joseph Waston, Irmgard Behlau |
| 49 |
[GO] |
2022―Mar―07 |
Secondary Infection Risk in Patients With Severe COVID-19 Pneumonia Treated With Tocilizumab |
Gagangeet Sandhu, Samuel T. Piraino, Joshua Piticaru |
| 50 |
[GO] |
2022―Feb―17 |
Expression of Concern for Bryant a, Lawrie TA, Dowswell T, Fordham EJ, Mitchell S, Hill SR, Tham TC. Ivermectin for Prevention and Treatment of COVID-19 Infection |
Peter Manu |
| 51 |
[GO] |
2022―Feb―14 |
Meta-Analyses Do Not Establish Improved Mortality With Ivermectin Use in COVID-19 |
Steven G. Rothrock, Kurt D. Weber, Philip A. Giordano, Mitchell D. Barneck |
| 52 |
[GO] |
2022―Feb―10 |
Expression of Concern for Kory P, Meduri GU, Varon J, Iglesias J, Marik PE. Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19. Am J Ther. 2021;28(3) |
Peter Manu |
| 53 |
[GO] |
2022―Feb―10 |
Expression of Concern for Bryant a, Lawrie TA, Dowswell T, Fordham EJ, Mitchell S, Hill SR, Tham TC. Ivermectin for Prevention and Treatment of COVID-19 Infection |
Peter Manu |
| 54 |
[GO] |
2022―Jan―14 |
Acute Cardiac Events After ChAdOx1 nCoV-19 Corona Virus Vaccine |
Rohit Singh, Sankha Shubhra Chakrabarti, Indrajeet Singh Gambhir, Ashish Verma, Ishan Kumar, Soumik Ghosh, et al. (+4) Ashutosh Tiwari, Gourav Chandan, Sasanka Chakrabarti, Upinder Kaur |
| 55 |
[GO] |
2022―Jan―07 |
Meta-Analyses Do Not Establish Improved Mortality With Ivermectin Use in COVID-19 |
Steven G. Rothrock, Kurt D. Weber, Philip A. Giordano, Mitchell D. Barneck |
| 56 |
[GO] |
2022―Jan―05 |
Re: “Commentary” by Rothrock et al. “Meta-Analyses Did Not Establish Improved Mortality With Ivermectin Use in COVID-19” |
Andrew Bryant, Theresa A. Lawrie, Edmund J. Fordham, Scott Mitchell |
| 57 |
[GO] |
2021―Dec―04 |
Anticoagulation Management and Outcomes in Patients With Covid-19 With Propensity Score Matching |
Jasmeet Kaur, Jennifer deLongpre, Tracy Koehler, Heather Laclair, Monica Bowen, Justin Khine, et al. (+8) Nadia Khosrodad, Nihar Jena, Priyadarshini Dixit, Sumeet Yadav, Swathi M. Mogulla, Rob Coakley, Anupam Sule, Geetha Krishnamoorthy |
| 58 |
[GO] |
2021―Nov―10 |
Treatment Challenges of ST-Segment Elevation Myocardial Infarction Within the Constraint of COVID-19 Pandemic |
Hammam Shereef, Ahmed S. Yassin, Ahmed Subahi, Omar Ali |
| 59 |
[GO] |
2021―Nov―10 |
Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19: Erratum |
|
| 60 |
[GO] |
2021―Oct―26 |
Malignant Hyperthermia and Cisatracurium During Severe SARS-CoV-2 Infection |
Ju-Tae Sohn |
| 61 |
[GO] |
2021―Oct―26 |
Romiplostim for SARS-CoV-2 Vaccine Induced Immune Thrombocytopenia |
Ziad Abuhelwa, Ying Ning, Waleed Abdulsattar, Sami Ghazaleh, Navkirat Kahlon, Ahmed Elsayed |
| 62 |
[GO] |
2021―Sep―02 |
Intensive Treatment With Ivermectin and Iota-Carrageenan as Pre-exposure Prophylaxis for COVID-19 in Health Care Workers From Tucuman, Argentina |
Rossana E. Chahla, Luis Medina Ruiz, Eugenia S. Ortega, Marcelo F. Morales, Francisco Barreiro, Alexia George, et al. (+5) Cesar Mancilla, Sylvia D' Amato, Guillermo Barrenechea, Daniel G. Goroso, Maria Peral de Bruno |
| 63 |
[GO] |
2021―Sep―02 |
Ivermectin for Prevention and Treatment of COVID-19 Infection |
Andrew Bryant, Theresa A. Lawrie, Edmund J. Fordham |
| 64 |
[GO] |
2021―Aug―13 |
Pitfalls in Reporting Sample Size Calculation Across Randomized Controlled Trials Involving Ivermectin for the treatment of COVID-19 |
Chia Siang Kow, Syed S. Hasan |
| 65 |
[GO] |
2021―Aug―13 |
Cisatracurium-Associated Malignant Hyperthermia During Severe Sars-CoV-2 Infection |
Swaminathan P. Sathyanarayanan, Muhammad Hamza, Khizar Hamid, Dayna Groskreutz |
| 66 |
[GO] |
2021―Jul―29 |
Effect of Subcutaneous Tocilizumab on Mortality in Patients With COVID-19 |
Tzu Rong Peng, Ta Wei Wu, An Jan Wu |
| 67 |
[GO] |
2021―Jul―15 |
Tocilizumab Induces Rapid, Sustained Improvement of Inflammatory Markers in COVID-19, With Clinical Improvement in Most Patients |
Scott J. Morin, Chinmay Jani, Arashdeep Rupal, Harpreet Singh, Daniel Bourque, Robert C. Colgrove |
| 68 |
[GO] |
2021―Jul―05 |
Increased Mortality in Antecedent Combined Renin-Angiotensin System Inhibitors and Antiplatelets Compared With Antiplatelets Alone in Hospitalized Patients With COVID-19 |
Yi Lee, Qasim Jehangir, Jasmeet Kaur, Asrar Abdou, Mohammed Ibrahim, Mohamed N. Mandeel, et al. (+6) Priyadarshini Dixit, Amar Lal, Mayuri Kulkarni, Yaqub N. Mohammed, Priyanjali Pulipati, Jacky Duong |
| 69 |
[GO] |
2021―Jun―19 |
Ivermectin for Prevention and Treatment of COVID-19 Infection |
Andrew Bryant, Theresa A. Lawrie, Therese Dowswell, Edmund J. Fordham, Scott Mitchell, Sarah R. Hill, Tony C. Tham |
| 70 |
[GO] |
2021―Jun―12 |
Clinical Features and Lymphocyte Subsets in Recovered COVID-19 Patients With Prolonged Viral RNA Shedding Duration |
Wei-Yun Zhang, Jia-Jia Wang, Ying-Ying Liu, Da-Xiong Zeng |
| 71 |
[GO] |
2021―Jun―12 |
Tocilizumab-Associated Cecal Perforation in COVID-19 Pneumonia |
Josephine Adunse, Nithin Kesireddy, Waleed Khokher, Prabath Herath Mudiyanselage, Hyder Ali, Ragheb Assaly |
| 72 |
[GO] |
2021―Jun―12 |
Immune Thrombocytopenic Purpura Associated With Pfizer-BioNTech COVID-19 Vaccine Refractory to Conventional Treatment |
Ghulam Ghous, Allahyar ., Muhammad Usman Zafar, Zahid Ijaz Tarar, Hafiz Muhammad Hassan Shoukat |
| 73 |
[GO] |
2021―Jun―12 |
Colchicine Treatment in SARS-CoV-2 Infection |
Azizullah Beran, Mohammed Mhanna, Waseem Wahood, Sami Ghazaleh, Omar Sajdeya, Muhamad Kalifa, et al. (+5) Hazem Ayesh, Omar Srour, Asmaa S. Mhanna, Nezam Altorok, Ragheb Assaly |
| 74 |
[GO] |
2021―Jun―12 |
A Global Early Empirical Therapy Randomized Study Design for Ivermectin in SARS-CoV-2 Infection |
Emmanuel Bhaskar |
| 75 |
[GO] |
2021―May―05 |
Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19 |
Pierre Kory, Gianfranco Umberto Meduri, Joseph Varon, Jose Iglesias, Paul E. Marik |
| 76 |
[GO] |
2021―May―05 |
COVID-19 Vaccine-Associated Takotsubo Cardiomyopathy |
Chinmay Jani, Jeffrey Leavitt, Omar Al Omari, Alana Dimaso, Kyle Pond, Stephen Gannon, et al. (+3) Arun Kumar Chandran, Christopher Dennis, Robert Colgrove |
| 77 |
[GO] |
2021―Apr―17 |
Arrhythmias in Patients With Coronavirus Disease 2019 Treated With Hydroxychloroquine and/or Azithromycin |
Urvashi Hooda, Nicholas Feola, Christopher Nabors, Abhay Dhand |
| 78 |
[GO] |
2021―Mar―09 |
Digital Health Technology and Telemedicine-Based Hospital and Home Programs in Pulmonary Medicine During the COVID-19 Pandemic |
Jonathan Ilowite, Gita Lisker, Harly Greenberg |
| 79 |
[GO] |
2021―Jan―13 |
Heparin-Induced Thrombocytopenia in a Patient With Coronavirus Disease-19 |
Tariq Kewan, Fahrettin Covut, Hamed Daw, Abdo Haddad |
| 80 |
[GO] |
2021―Jan―13 |
Effects of Hydroxychloroquine With or Without Azithromycin on QT Interval in COVID-19 |
Siddharth Shah, Kuldeep Shah, Mohit K. Turagam, Dhanunjaya Lakkireddy, Jalaj Garg |
| 81 |
[GO] |
2021―Jan―04 |
Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and the Risk of SARS-CoV-2 Infection or Hospitalization With COVID-19 Disease |
Imad M. Tleyjeh, Aref A. Bin Abdulhak, Haytham Tlayjeh, Mouaz H. Al-Mallah, M. Rizwan Sohail, Leslie C. Hassett, et al. (+2) Jolanta M. Siller-Matula, Tarek Kashour |
| 82 |
[GO] |
2020―Dec―25 |
COVID-19 and Renin Angiotensin Aldosterone System: A Pharmacogenomic View |
Ehab S. EL Desoky |
| 83 |
[GO] |
2020―Dec―25 |
Anticoagulant Protein S in COVID-19: The Low Activity Level Is Probably Secondary |
Cristian Baicus, Laura Elena Stoichitoiu, Larisa Pinte, Camelia Badea |
| 84 |
[GO] |
2020―Nov―19 |
Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Mortality Among COVID-19 Patients |
Tarek Kashour, Aref A. Bin Abdulhak, Haytham Tlayjeh, Leslie C. Hassett, Anas Noman, Ala Mohsen, et al. (+2) Mouaz H. Al-Mallah, Imad M. Tleyjeh |
| 85 |
[GO] |
2020―Nov―05 |
Venous Thromboembolism in Hospitalized COVID-19 Patients |
Gurusaravanan Kutti Sridharan, Radhakrishna Vegunta, Venkata Ram Pradeep Rokkam, Veeraraghavan Meyyur Aravamudan, Rathnamitreyee Vegunta, Shahab R. Khan, et al. (+5) Suresh Ponnada, Umesha Boregowda, Kalyan Prudhvi, Gajapathiraju Chamarthi, Babu P. Mohan |
| 86 |
[GO] |
2020―Nov―02 |
Hydroxychloroquine and COVID-19 |
Cosima Rughiniş, Lorena Dima, Sorina Vasile |
| 87 |
[GO] |
2020―Oct―06 |
Tocilizumab-Associated Bowel Perforation in SARS-CoV-2 Infection |
Purva Ranchal, Evan Yates, Rahul Gupta, Wilbert S. Aronow |
| 88 |
[GO] |
2020―Aug―14 |
Vitamin D Supplementation in COVID-19 Patients |
Kim C. Ohaegbulam, Mohamed Swalih, Pranavkumar Patel, Miriam A. Smith, Richard Perrin |
| 89 |
[GO] |
2020―Aug―05 |
Shedding Light on COVID-19 |
Brittany Schreiber, Ankit Patel, Ashish Verma |
| 90 |
[GO] |
2020―May―04 |
Prolonged Viral RNA Shedding Duration in COVID-19 |
Wei-yun Zhang, Le-qun Yu, Jian-an Huang, Da-Xiong Zeng |
| 91 |
[GO] |
2020―May―04 |
COVID-19 and Avoiding Ibuprofen. How Good Is the Evidence? |
Gurusaravanan Kutti Sridharan, Rajesh Kotagiri, Vijay H. Chandiramani, Babu P. Mohan, Rathnamitreyee Vegunta, Radhakrishna Vegunta, Venkata R. P. Rokkam |
